Copyright © 2014, Community Newspaper Holdings Inc.
A Norman diagnostics development company was among those honored with the 2014 Oklahoma BioScience Recognition Awards recently. Presented by the Oklahoma Bioscience Association, the recipients were recognized at an awards dinner at the Skirvin Hilton Hotel. IMMY, a Norman-based diagnostic development company, operated by brothers Sean Bauman and Scott Bauman, was given the Innovation Recognition Award.
“We’re proud to be honoring such an outstanding group of Oklahoma researchers, educators and innovative organizations,” said Scott Meacham, CEO of i2E Inc. and the Oklahoma Bioscience Association. “Each of them has made significant contributions to the state’s bioscience community in ways that transcend the direct impact of their work.”
IMMY is quickly becoming an innovative leader in the world of fungal diagnostics. The company has developed a dipstick test that detects cryptococcal antigen, a fungus that kills more than 600,000 people every year, claiming more lives than tuberculosis among HIV/AIDs patients in Sub-Saharan Africa. IMMY is making a global impact on the prevention of HIV-associated deaths in the developing world with its affordable diagnostic technology.